Reactions 1704, p51 - 2 Jun 2018 Drug eruption: case report A 48-year-old woman developed drug eruption following treatment with artemether/lumefantrine [Riamet] for malaria [routes and time to reaction onset not stated]. The woman presented with a five-day history of annular hyperpigmented plaques along with intense pruritus and peripheral vesiculation on the trunk extended to the lower limbs. Five days prior to the presentation, she was diagnosed with malaria and started receiving treatment with artemether 20mg/lumefantrine 120mg for over 60 hours. A histology demonstrated a severe eosinophilic vesicular spongiotic eruption, secondary to the drug. The woman was treated with an optimised topical therapy, after which an improvement was observed over 72 hours. Author comment: "Excepting a bullous eruption reported to the FDA in 2012, which is not documented in the literature, this is the first dermatological complication from [artemether/lumefantrine] aside from generalised pruritus or urticarial rash." "Histology showed severe eosinophilic vesicular spongiotic eruption, likely secondary to a drug." Hishon M, et al. Case report: "Cluster of jewels" drug eruption to malarial treatment Riamet (artemether/lumefantrine). Australasian Journal of Dermatology 59 (Suppl. 1): 69-70, May 2018. Available from: URL: http://doi.org/10.1111/ ajd.17_12815 [abstract] - Australia 803323564 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704
Reactions Weekly – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera